Sucampo Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Sucampo Pharmaceuticals's estimated annual revenue is currently $9.4M per year.
- Sucampo Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Sucampo Pharmaceuticals has 47 Employees.
- Sucampo Pharmaceuticals grew their employee count by 0% last year.
Sucampo Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Research and Development | Reveal Email/Phone |
Sucampo Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7M | 35 | -3% | N/A | N/A |
#2 | $7.2M | 36 | -5% | N/A | N/A |
#3 | $10.5M | 52 | -9% | N/A | N/A |
#4 | $344.1M | 1712 | 9% | N/A | N/A |
#5 | $27.5M | 137 | 6% | N/A | N/A |
#6 | $107.3M | 534 | 9% | N/A | N/A |
#7 | $12.9M | 64 | 28% | N/A | N/A |
#8 | $31.6M | 157 | 1% | N/A | N/A |
#9 | $31.4M | 156 | 7% | N/A | N/A |
#10 | $11.5M | 57 | 30% | N/A | N/A |
What Is Sucampo Pharmaceuticals?
Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG.
keywords:N/AN/A
Total Funding
47
Number of Employees
$9.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sucampo Pharmaceuticals News
... some of the players studied are: Nestle , Abbot Laboratories , Synergy Pharmaceuticals , Sucampo Pharmaceuticals , Novartis , Astellas Pharmaceuticals.
... Bowel Syndrome with Constipation Drugs Market Size 2022-2030| Key Players Nestle, Abbot Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals.
... Amarantus BioScience, Ocugen, ReGenX Biosciences, Sucampo Pharmaceuticals, Orphagen Pharmaceuticals, Okuvision, Second Sight Medical.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 47 | 4% | N/A |
#2 | $8.8M | 47 | 0% | $147.4M |
#3 | N/A | 48 | 2% | N/A |
#4 | $8.1M | 48 | 9% | N/A |
#5 | $10.4M | 48 | 14% | N/A |